Healing the Body With Photobiomodulation

By Dr. Mercola Photobiomodulation therapy has important implications for health that many are still under-informed about. In this interview, photodynamic therapy researcher Michael Hamblin, Ph.D., who is an expert in this area, sets out to improve our understanding of this important field. Hamblin is a researcher and associate professor of dermatology at Harvard Medical School. He’s also a principal investigator at The Wellman Center for Photomedicine at Massachusetts General Hospital, and a member of the Harvard-MIT Division of Health Sciences and Technology. Infrared therapy is one aspect of photobiomodulation, which covers light of all wavelengths — visible light, and light from spectral regions including ultraviolet, blues through the green, red and into the near-, mid- and far-infrared wavelengths. One of the most commonly used wavelengths of light is the near-infrared, which starts at about 750 nanometers (nm) and goes all the way into 1,200 nm. Near-infrared in the lower ra
http://articles.mercola.com/sites/articles/archive/2017/02/26/photobiomodulation.aspx